Antimicrobial photosensitizers: Drug discovery under the spotlight

Current Medicinal Chemistry

Volumn 22, Issue 18, 2015, Pages 2159-2185

  Yin, Rui ^a,b,c   Hamblin, Michael R ^b,c,d  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

Antimicrobial photodynamic therapy; Bacteria; Bacteriochlorin; Chlorin; Fullerene; Fungi; Infection; Natural product; Phenothiazinium salt; Phthalocyanine; Porphyrin; Titania photocatalysis; Xanthene dye

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIOCHLORIN; CURCUMIN; DIPYRROMETHENEBORON DIFLUORIDE; FULLERENE DERIVATIVE; HYPERICIN; INDOCYANINE GREEN; METHYLENE BLUE; PERYLENEQUINONE; PHOTOSENSITIZING AGENT; PHTHALOCYANINE DERIVATIVE; POLYPYRROLE; PORPHYRIN DERIVATIVE; PSORALEN DERIVATIVE; QUINONE DERIVATIVE; RIBOFLAVIN; TITANIUM DIOXIDE; TOLONIUM CHLORIDE; UNCLASSIFIED DRUG; XANTHENE;

ACNE VULGARIS; DERMATOMYCOSIS; DRUG MECHANISM; DRUG STRUCTURE; HELICOBACTER INFECTION; HUMAN; MOUTH MYCOSIS; MYCOSIS; ONYCHOMYCOSIS; PHOTOCATALYSIS; PHOTODYNAMIC THERAPY; REVIEW; TOOTH INFECTION; WOUND INFECTION; ANIMAL; BACTERIUM; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DEVELOPMENT; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; PHOTOCHEMOTHERAPY;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; DRUG DISCOVERY; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 84934325552     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867322666150319120134     Document Type: Review

References (234)

1. Raab, O. Ueber die wirkung fluorizierender stoffe auf infusorien. Z Biol., 1900, 39, 524-546.
2. von Tappeiner, H. Zur Kenntnis der lichtwirkenden (fluoreszierenden) Stoffe. Dtsch. Med. Wochenschr, 1904, 1, 579-580.
3. Tappeiner Hv, J.A. Über die Wirkung der photodynamischen (fluoreszierenden) Stoffe auf Infusorien. Dtsch. Arch. Klin. Med. 1904, 80, 427-487.
4. Bonnett, R. Photodynamic therapy in historical perspective. Rev. Contemp. Pharmacother., 1999, 10, 1-17.
5. Nyman, E.S.; Hynninen, P.H. Research advances in the use of tetrapyrrolic photosensitizers for photodynamic therapy. J. Photochem. Photobiol. B, 2004, 73(1-2), 1-28.
6. Hamblin, M.R.; Hasan, T. Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem. Photobiol. Sci., 2004, 3(5), 436-450.
7. Nicolau, D.P. Current challenges in the management of the infected patient. Curr. Opin. Infect. Dis., 2011, 24 (Suppl) 1, S1-10.
8. Norrby, S.R.; Nord, C.E.; Finch, R. European Society of Clinical, M.; Infectious, D., Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect. Dis., 2005, 5(2), 115-119.
9. Agostinis, P.; Berg, K.; Cengel, K.A.; Foster, T.H.; Girotti, A.W.; Gollnick, S.O.; Hahn, S.M.; Hamblin, M.R.; Juzeniene, A.; Kessel, D.; Korbelik, M.; Moan, J.; Mroz, P.; Nowis, D.; Piette, J.; Wilson, B.C.; Golab, J. Photodynamic therapy of cancer: an update. CA Cancer J. Clin., 2011, 61(4), 250-281.
10. Dolmans, D.E.; Fukumura, D.; Jain, R.K. Photodynamic therapy for cancer. Nat. Rev. Cancer, 2003, 3(5), 380-387.
11. Foote, C.S. Definition of type I and type II photosensitized oxidation. Photochem. Photobiol., 1991, 54(5), 659.
12. Sharma, S.K.; Chiang, L.Y.; Hamblin, M.R. Photodynamic therapy with fullerenes in vivo: reality or a dream? Nanomedicine (Lond), 2011, 6(10), 1813-1825.
13. Detty, M.R.; Gibson, S.L.; Wagner, S.J. Current clinical and preclinical photosensitizers for use in photodynamic therapy. J. Med. Chem., 2004, 47(16), 3897-3915.
14. Henderson, B.W.; Dougherty, T.J. How does photodynamic therapy work? Photochem. Photobiol., 1992, 55(1), 145-157.
15. Fingar, V.H.; Mang, T.S.; Henderson, B.W. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice. Cancer Res., 1988, 48(12), 3350-3354.
16. Huang, L.; St Denis, T.G.; Xuan, Y.; Huang, Y.Y.; Tanaka, M.; Zadlo, A.; Sarna, T.; Hamblin, M.R. Paradoxical potentiation of methylene blue-mediated antimicrobial photodynamic inactivation by sodium azide: role of ambient oxygen and azide radicals. Free Radic. Biol. Med., 2012, 53(11), 2062-2071.
17. Nitzan, Y.; Gutterman, M.; Malik, Z.; Ehrenberg, B. Inactivation of gram-negative bacteria by photosensitized porphyrins. Photochem. Photobiol., 1992, 55(1), 89-96.
18. Malik, Z.; Ladan, H.; Nitzan, Y. Photodynamic inactivation of Gram-negative bacteria: problems and possible solutions. J. Photochem. Photobiol. B, 1992, 14(3), 262-266.
19. Bertoloni, G.; Rossi, F.; Valduga, G.; Jori, G.; van Lier, J. Photosensitizing activity of water- and lipid-soluble phthalocyanines on Escherichia coli. FEMS Microbiol. Lett., 1990, 59(1-2), 149-155.
20. Minnock, A.; Vernon, D.I.; Schofield, J.; Griffiths, J.; Parish, J.H.; Brown, S.B. Mechanism of uptake of a cationic water-soluble pyridinium zinc phthalocyanine across the outer membrane of Escherichia coli. Antimicrob. Agents Chemother., 2000, 44(3), 522-527.
21. Hamblin, M.R.; O'Donnell, D.A.; Murthy, N.; Rajagopalan, K.; Michaud, N.; Sherwood, M.E.; Hasan, T. Polycationic photosensitizer conjugates: effects of chain length and Gram classification on the photodynamic inactivation of bacteria. J. Antimicrob. Chemother., 2002, 49(6), 941-951.
22. Ferro, S.; Ricchelli, F.; Monti, D.; Mancini, G.; Jori, G. Efficient photoinactivation of methicillin-resistant Staphylococcus aureus by a novel porphyrin incorporated into a poly-cationic liposome. Int. J. Biochem. Cell Biol., 2007, 39(5), 1026-1034.
23. Demidova, T.N.; Hamblin, M.R. Effect of cell-photosensitizer binding and cell density on microbial photoinactivation. Antimicrob. Agents Chemother., 2005, 49(6), 2329-2335.
24. de Melo, W.C.; Avci, P.; de Oliveira, M.N.; Gupta, A.; Vecchio, D.; Sadasivam, M.; Chandran, R.; Huang, Y.Y.; Yin, R.; Perussi, L.R.; Tegos, G.P.; Perussi, J.R.; Dai, T.; Hamblin, M.R. Photodynamic inactivation of biofilm: taking a lightly colored approach to stubborn infection. Expert Rev. Anti Infect. Ther., 2013, 11(7), 669-693.
25. Szeimies, R.M.; Karrer, S.; Abels, C.; Steinbach, P.; Fickweiler, S.; Messmann, H.; Baumler, W.; Landthaler, M. 9-Acetoxy-2,7,12,17-tetrakis-(beta-methoxyethyl)-porphycene (ATMPn), a novel photosensitizer for photodynamic therapy: uptake kinetics and intracellular localization. J. Photochem. Photobiol. B, 1996, 34(1), 67-72.
26. Harris, F.; Chatfield, L.K.; Phoenix, D.A. Phenothiazinium based photosensitisers--photodynamic agents with a multiplicity of cellular targets and clinical applications. Curr. Drug. Targets, 2005, 6(5), 615-627.
27. Wainwright, M.; Phoenix, D.A.; Rice, L.; Burrow, S.M.; Waring, J. Increased cytotoxicity and phototoxicity in the methylene blue series via chromophore methylation. J. Photochem. Photobiol. B, 1997, 40(3), 233-239.
28. Bottiroli, G.; Croce, A.C.; Balzarini, P.; Locatelli, D.; Baglioni, P.; Lo Nostro, P.; Monici, M.; Pratesi, R. Enzyme-assisted cell photosensitization: a proposal for an efficient approach to tumor therapy and diagnosis. The rose bengal fluorogenic substrate. Photochem. Photobiol., 1997, 66(3), 374-383.
29. Lai, Y.C.; Su, S.Y.; Chang, C.C. Special reactive oxygen species generation by a highly photostable BODIPY-based photosensitizer for selective photodynamic therapy. ACS Appl. Mater Interfaces., 2013, 5(24), 12935-12943.
30. Lim, S.H.; Thivierge, C.; Nowak-Sliwinska, P.; Han, J.; van den Bergh, H.; Wagnieres, G.; Burgess, K.; Lee, H.B. In vitro and in vivo photocytotoxicity of boron dipyrromethene derivatives for photodynamic therapy. J. Med. Chem., 2010, 53(7), 2865-2874.
31. Banfi, S.; Caruso, E.; Zaza, S.; Mancini, M.; Gariboldi, M.B.; Monti, E. Synthesis and photodynamic activity of a panel of BODIPY dyes. J. Photochem. Photobiol. B, 2012, 114, 52-60.
32. Dougherty, T.J. Hematoporphyrin as a photosensitizer of tumors. Photochem. Photobiol., 1983, 38(3), 377-379.
33. Dougherty, T.J.; Potter, W.R.; Weishaupt, K.R. The structure of the active component of hematoporphyrin derivative. Prog. Clin. Biol. Res., 1984, 170, 301-314.
34. Rywkin, S.; Ben-Hur, E.; Reid, M.E.; Oyen, R.; Ralph, H.; Horowitz, B. Selective protection against IgG binding to red cells treated with phthalocyanines and red light for virus inactivation. Transfusion, 1995, 35(5), 414-420.
35. Bellnier, D.A.; Dougherty, T.J. A preliminary pharmacokinetic study of intravenous Photofrin in patients. J. Clin. Laser Med. Surg., 1996, 14(5), 311-314.
36. Webber, J.; Kessel, D.; Fromm, D. Plasma levels of protoporphyrin IX in humans after oral administration of 5-aminolevulinic acid. J. Photochem. Photobiol. B, 1997, 37(1-2), 151-153.
37. Godal, A.; Nilsen, N.O.; Klaveness, J.; Branden, J.E.; Nesland, J.M.; Peng, Q. New derivatives of 5-aminolevulinic acid for photodynamic therapy: chemical synthesis and porphyrin production in in vitro and in vivo biological systems. J. Environ. Pathol. Toxicol. Oncol., 2006, 25(1-2), 109-126.
38. Harris, F.; Pierpoint, L. Photodynamic therapy based on 5-aminolevulinic acid and its use as an antimicrobial agent. Med. Res. Rev., 2012, 32(6), 1292-1327.
39. Kostovic, K.; Pastar, Z.; Ceovic, R.; Mokos, Z.B.; Buzina, D.S.; Stanimirovic, A. Photodynamic therapy in dermatology: current treatments and implications. Coll. Antropol., 2012, 36(4), 1477-1481.
40. Hongcharu, W.; Taylor, C.R.; Chang, Y.; Aghassi, D.; Suthamjariya, K.; Anderson, R.R, Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J. Invest. Dermatol., 2000, 115(2), 183-192.
41. Horn, M.; Wolf, P. Topical methyl aminolevulinate photodynamic therapy for the treatment of folliculitis. Photodermatol. Photoimmunol. Photomed., 2007, 23(4), 145-147.
42. Hillemanns, P.; Untch, M.; Prove, F.; Baumgartner, R.; Hillemanns, M.; Korell, M. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. Obstet. Gynecol., 1999, 93(1), 71-74.
43. Wiegell, S.R.; Kongshoj, B.; Wulf, H.C. Mycobacterium marinum infection cured by photodynamic therapy. Arch Dermatol., 2006, 142(9), 1241-1242.
44. van der Snoek, E.M.; Robinson, D.J.; van Hellemond, J.J.; Neumann, H.A. A review of photodynamic therapy in cutaneous leishmaniasis. J. Eur. Acad. Dermatol. Venereol., 2008, 22(8), 918-922.
45. Qiao, J.; Li, R.; Ding, Y.; Fang, H. Photodynamic therapy in the treatment of superficial mycoses: an evidence-based evaluation. Mycopathologia, 2010, 170(5), 339-343.
46. Rossi, R.; Bruscino, N.; Ricceri, F.; Grazzini, M.; Dindelli, M.; Lotti, T. Photodynamic treatment for viral infections of the skin. G. Ital. Dermatol. Venereol., 2009, 144(1), 79-83.
47. Tanaka, M.; Kinoshita, M.; Yoshihara, Y.; Shinomiya, N.; Seki, S.; Nemoto, K.; Hamblin, M.R.; Morimoto, Y. Photodynamic therapy using intra-articular Photofrin for murine MRSA arthritis: biphasic light dose response for neutrophil-mediated antibacterial effect. Lasers Surg. Med., 2011, 43(3), 221-229.
48. Mang, T.S.; Mikulski, L.; Hall, R.E., Photodynamic inactivation of normal and antifungal resistant Candida species. Photodiagnosis Photodyn. Ther., 2010, 7(2), 98-105.
49. Maisch, T.; Bosl, C.; Szeimies, R.M.; Lehn, N.; Abels, C. Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells. Antimicrob. Agents Chemother., 2005, 49(4), 1542-1552.
50. Ooi, N.; Miller, K.; Randall, C.; Rhys-Williams, W.; Love, W.; Chopra, I. XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms. J. Antimicrob. Chemother., 2010, 65(1), 72-78.
51. Ooi, N.; Miller, K.; Hobbs, J.; Rhys-Williams, W.; Love, W.; Chopra, I., XF-73 a novel antistaphylococcal membrane-active agent with rapid bactericidal activity. J. Antimicrob. Chemother., 2009, 64(4), 735-740.
52. Dovigo, L.N.; Pavarina, A.C.; Ribeiro, D.G.; Adriano, C.S.; Bagnato, V.S. Photodynamic inactivation of four Candida species induced by photogem((R)). Braz. J. Microbiol., 2010, 41(1), 42-49.
53. Mima, E.G.; Pavarina, A.C.; Dovigo, L.N.; Vergani, C.E.; Costa, C.A.; Kurachi, C.; Bagnato, V.S. Susceptibility of Candida albicans to photodynamic therapy in a murine model of oral candidosis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2010, 109(3), 392-401.
54. Ribeiro, D.G.; Pavarina, A.C.; Dovigo, L.N.; Mima, E.G.; Machado, A.L.; Bagnato, V.S.; Vergani, C.E. Photodynamic inactivation of microorganisms present on complete dentures. A clinical investigation. Photodynamic disinfection of complete dentures. Lasers Med. Sci., 2012, 27(1), 161-168.
55. Smijs, T.G.; van der Haas, R.N.; Lugtenburg, J.; Liu, Y.; de Jong, R.L.; Schuitmaker, H.J. Photodynamic treatment of the dermatophyte Trichophyton rubrum and its microconidia with porphyrin photosensitizers. Photochem. Photobiol., 2004, 80(2), 197-202.
56. Sbarra, M.S.; Arciola, C.R.; Di Poto, A.; Saino, E.; Rohde, H.; Speziale, P.; Visai, L. The photodynamic effect of tetra-substituted N-methyl-pyridyl-porphine combined with the action of vancomycin or host defense mechanisms disrupts Staphylococcus epidermidis biofilms. Int. J. Artif. Organs, 2009, 32(9), 574-583.
57. Saino, E.; Sbarra, M.S.; Arciola, C.R.; Scavone, M.; Bloise, N.; Nikolov, P.; Ricchelli, F.; Visai, L. Photodynamic action of Trimeso (N-methyl-pyridyl), meso (N-tetradecyl-pyridyl) porphine on Staphylococcus epidermidis biofilms grown on Ti6Al4V alloy. Int. J. Artif. Organs, 2010, 33(9), 636-645.
58. Alves, E.; Costa, L.; Carvalho, C.M.; Tome, J.P.; Faustino, M.A.; Neves, M.G.; Tome, A.C.; Cavaleiro, J.A.; Cunha, A.; Almeida, A. Charge effect on the photoinactivation of Gram-negative and Gram-positive bacteria by cationic meso-substituted porphyrins. BMC Microbiol., 2009, 9, 70.
59. de Visscher, S.A.; Dijkstra, P.U.; Tan, I.B.; Roodenburg, J.L.; Witjes, M.J. mTHPC mediated photodynamic therapy (PDT) of squamous cell carcinoma in the head and neck: a systematic review. Oral Oncol., 2013, 49(3), 192-210.
60. Kranz, S.; Guellmar, A.; Volpel, A.; Gitter, B.; Albrecht, V.; Sigusch, B.W. Photodynamic suppression of Enterococcus faecalis using the photosensitizer mTHPC. Lasers Surg. Med., 2011, 43(3), 241-248.
61. Yang, K.; Gitter, B.; Ruger, R.; Albrecht, V.; Wieland, G.D.; Fahr, A. Wheat germ agglutinin modified liposomes for the photodynamic inactivation of bacteria. Photochem. Photobiol., 2012, 88(3), 548-556.
62. Tegos, G.P.; Anbe, M.; Yang, C.; Demidova, T.N.; Satti, M.; Mroz, P.; Janjua, S.; Gad, F.; Hamblin, M.R. Protease-stable polycationic photosensitizer conjugates between polyethyleneimine and chlorin(e6) for broad-spectrum antimicrobial photoinactivation. Antimicrob. Agents Chemother., 2006, 50(4), 1402-1410.
63. Gad, F.; Zahra, T.; Hasan, T.; Hamblin, M.R. Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria. Antimicrob Agents Chemother., 2004, 48(6), 2173-2178.
64. Dabrowski, J.M.; Arnaut, L.G.; Pereira, M.M.; Monteiro, C.J.; Urbanska, K.; Simoes, S.; Stochel, G. New halogenated watersoluble chlorin and bacteriochlorin as photostable PDT sensitizers: synthesis, spectroscopy, photophysics, and in vitro photosensitizing efficacy. Chem. Med. Chem., 2010, 5(10), 1770-1780.
65. Ashur, I.; Goldschmidt, R.; Pinkas, I.; Salomon, Y.; Szewczyk, G.; Sarna, T.; Scherz, A. Photocatalytic generation of oxygen radicals by the water-soluble bacteriochlorophyll derivative WST11, noncovalently bound to serum albumin. J. Phys. Chem. A, 2009, 113(28), 8027-8037.
66. Yakubovskaya, R.I.; Plotnikova, C.; Plyutinskaya, A.D.; Morozova, N.B.; Chissov, V.I.; Makarova, E.A.; Dudkin, S.V.; Lukyanets, E.A.; Vorozhtsov, G.N. Photophysical properties and in vitro and in vivo photoinduced antitumor activity of cationic salts of meso-tetrakis(N-alkyl-3-pyridyl)bacteriochlorins. J. Photochem. Photobiol. B, 2014, 130, 109-114.
67. Aggarwal, A.; Thompson, S.; Singh, S.; Newton, B.; Moore, A.; Gao, R.; Gu, X.; Mukherjee, S.; Drain, C.M. Photophysics of glycosylated derivatives of a chlorin, isobacteriochlorin and bacteriochlorin for photodynamic theragnostics: discovery of a two-photonabsorbing photosensitizer. Photochem. Photobiol. 2013, in press.
68. Schastak, S.; Ziganshyna, S.; Gitter, B.; Wiedemann, P.; Claudepierre, T. Efficient photodynamic therapy against gram-positive and gram-negative bacteria using THPTS, a cationic photosensitizer excited by infrared wavelength. PLoS One, 2010, 5(7), e11674.
69. Taniguchi, M.; Cramer, D.L.; Bhise, A.D.; Kee, H.L.; Bocian, D.F.; Holten, D.; Lindsey, J.S., Accessing the near-infrared spectral region with stable, synthetic, wavelength-tunable bacteriochlorins. New J. Chem., 2008, 32, 947-958.
70. Yang, E.; Kirmaier, C.; Krayer, M.; Taniguchi, M.; Kim, H.J.; Diers, J.R.; Bocian, D.F.; Lindsey, J.S.; Holten, D. Photophysical properties and electronic structure of stable, tunable synthetic bacteriochlorins: extending the features of native photosynthetic pigments. J. Phys. Chem. B, 2011, 115(37), 10801-10816.
71. Ruzie, C.; Krayer, M.; Balasubramanian, T.; Lindsey, J.S. Tailoring a bacteriochlorin building block with cationic, amphipathic, or lipophilic substituents. J. Org. Chem., 2008, 73(15), 5806-5820.
72. Aravindu, K.; Mass, O.; Vairaprakash, P.; Springer, J.W.; Yang, E.; Niedzwiedzki, D.M.; Bocian, D.F.; Holten, D.; Lindsey, J.S. Amphiphilic chlorins and bacteriochlorins in micellar environments. Molecular design, de novo synthesis, and photophysical properties. Chem. Sci., 2013, 4, 3459-3477.
73. Huang, L.; Huang, Y.Y.; Mroz, P.; Tegos, G.P.; Zhiyentayev, T.; Sharma, S.K.; Lu, Z.; Balasubramanian, T.; Krayer, M.; Ruzie, C.; Yang, E.; Kee, H.L.; Kirmaier, C.; Diers, J.R.; Bocian, D.F.; Holten, D.; Lindsey, J.S.; Hamblin, M.R. Stable synthetic cationic bacteriochlorins as selective antimicrobial photosensitizers. Antimicrob. Agents Chemother., 2010, 54(9), 3834-3841.
74. Mantareva, V.; Angelov, I.; Kussovski, V.; Dimitrov, R.; Lapok, L.; Wohrle, D. Photodynamic efficacy of water-soluble Si(IV) and Ge(IV) phthalocyanines towards Candida albicans planktonic and biofilm cultures. Eur. J. Med. Chem., 2011, 46(9), 4430-4440.
75. Kussovski, V.; Mantareva, V.; Angelov, I.; Orozova, P.; Wohrle, D.; Schnurpfeil, G.; Borisova, E.; Avramov, L. Photodynamic inactivation of Aeromonas hydrophila by cationic phthalocyanines with different hydrophobicity. FEMS Microbiol. Lett., 2009, 294 (2), 133-140.
76. Mantareva, V.; Kussovski, V.; Angelov, I.; Wohrle, D.; Dimitrov, R.; Popova, E.; Dimitrov, S. Non-aggregated Ga(III)- phthalocyanines in the photodynamic inactivation of planktonic and biofilm cultures of pathogenic microorganisms. Photochem. Photobiol. Sci., 2011, 10(1), 91-102.
77. Ribeiro, A.P.; Andrade, M.C.; da Silva Jde, F.; Jorge, J.H.; Primo, F.L.; Tedesco, A.C.; Pavarina, A.C. Photodynamic inactivation of planktonic cultures and biofilms of Candida albicans mediated by aluminum-chloride-phthalocyanine entrapped in nanoemulsions. Photochem. Photobiol., 2013, 89(1), 111-119.
78. Soncin, M.; Fabris, C.; Busetti, A.; Dei, D.; Nistri, D.; Roncucci, G.; Jori, G. Approaches to selectivity in the Zn(II)-phthalocyanine-photosensitized inactivation of wild-type and antibiotic-resistant Staphylococcus aureus. Photochem. Photobiol. Sci., 2002, 1(10), 815-819.
79. Giuliani, F.; Martinelli, M.; Cocchi, A.; Arbia, D.; Fantetti, L.; Roncucci, G., In vitro resistance selection studies of RLP068/Cl, a new Zn(II) phthalocyanine suitable for antimicrobial photodynamic therapy. Antimicrob. Agents Chemother., 2010, 54(2), 637-642.
80. Simonetti, O.; Cirioni, O.; Orlando, F.; Alongi, C.; Lucarini, G.; Silvestri, C.; Zizzi, A.; Fantetti, L.; Roncucci, G.; Giacometti, A.; Offidani, A.; Provinciali, M. Effectiveness of antimicrobial photodynamic therapy with a single treatment of RLP068/Cl in an experimental model of Staphylococcus aureus wound infection. Br. J. Dermatol., 2011, 164(5), 987-995.
81. Vecchio, D.; Dai, T.; Huang, L.; Fantetti, L.; Roncucci, G.; Hamblin, M.R. Antimicrobial photodynamic therapy with RLP068 kills methicillin-resistant Staphylococcus aureus and improves wound healing in a mouse model of infected skin abrasion PDT with RLP068/Cl in infected mouse skin abrasion. J. Biophotonics., 2013, 6(9), 733-742.
82. Konig, K.; Genze, F.; Miller, K.; Ruck, A.; Reich, E.; Repassy, D. Photodynamic activity of liposome-delivered Cd-texaphyrin using tumor-bearing nude mice. Lasers Surg. Med., 1993, 13(5), 522-527.
83. Nitzan, Y.; Balzam-Sudakevitz, A.; Ashkenazi, H. Eradication of Acinetobacter baumannii by photosensitized agents in vitro. J. Photochem. Photobiol. B, 1998, 42(3), 211-218.
84. Sanchez-Garcia, D.; Sessler, J.L. Porphycenes: synthesis and derivatives. Chem. Soc. Rev., 2008, 37(1), 215-232.
85. Ragas, X.; Sanchez-Garcia, D.; Ruiz-Gonzalez, R.; Dai, T.; Agut, M.; Hamblin, M.R.; Nonell, S. Cationic porphycenes as potential photosensitizers for antimicrobial photodynamic therapy. J. Med. Chem., 2010, 53, 7796-7803.
86. Gupta, K.K.; Bharne, S.S.; Rathinasamy, K.; Naik, N.R.; Panda, D., Dietary antioxidant curcumin inhibits microtubule assembly through tubulin binding. FEBS J., 2006, 273(23), 5320-5332.
87. Ruby, A.J.; Kuttan, G.; Babu, K.D.; Rajasekharan, K.N.; Kuttan, R. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett., 1995, 94(1), 79-83.
88. Winter, S.; Tortik, N.; Kubin, A.; Krammer, B.; Plaetzer, K. Back to the roots: photodynamic inactivation of bacteria based on watersoluble curcumin bound to polyvinylpyrrolidone as a photosensitizer. Photochem. Photobiol. Sci., 2013, 12(10), 1795-1802.
89. Dovigo, L.N.; Pavarina, A.C.; Ribeiro, A.P.; Brunetti, I.L.; Costa, C.A.; Jacomassi, D.P.; Bagnato, V.S.; Kurachi, C. Investigation of the photodynamic effects of curcumin against Candida albicans. Photochem. Photobiol., 2011, 87(4), 895-903.
90. Paschoal, M.A.; Lin, M.; Santos-Pinto, L.; Duarte, S. Photodynamic antimicrobial chemotherapy on Streptococcus mutans using curcumin and toluidine blue activated by a novel LED device. Lasers Med. Sci., 2015, 30(2), 885-890.
91. Paschoal, M.A.; Tonon, C.C.; Spolidorio, D.M.; Bagnato, V.S.; Giusti, J.S.; Santos-Pinto, L., Photodynamic potential of curcumin and blue LED against Streptococcus mutans in a planktonic culture. Photodiagnosis Photodyn. Ther., 2013, 10(3), 313-319.
92. Tovsen, M.L.; Bruzell, E.; Ferrari, E.; Saladini, M.; Gaware, V.S.; Masson, M.; Kristensen, S.; Tonnesen, H.H. Antibacterial phototoxic effects of synthetic asymmetric and glycosylated curcuminoids in aqueous formulations: Studies on curcumin and curcuminoids. LIV. J. Photochem. Photobiol. B, 2014, 140C, 150-156.
93. Manoil, D.; Filieri, A.; Gameiro, C.; Lange, N.; Schrenzel, J.; Wataha, J.C.; Bouillaguet, S. Flow cytometric assessment of Streptococcus mutans viability after exposure to blue light-activated curcumin. Photodiagnosis Photodyn. Ther., 2014, 11(3), 372-379.
94. Araujo, N.C.; Fontana, C.R.; Bagnato, V.S.; Gerbi, M.E. Photodynamic effects of curcumin against cariogenic pathogens. Photomed. Laser Surg., 2012, 30(7), 393-399.
95. Araujo, N.C.; Fontana, C.R.; Gerbi, M.E.; Bagnato, V.S. Overallmouth disinfection by photodynamic therapy using curcumin. Photomed. Laser Surg., 2012, 30(2), 96-101.
96. Craig, J.A.; Mahon, J.; Yellowlees, A.; Barata, T.; Glanville, J.; Arber, M.; Mandava, L.; Powell, J.; Figueiredo, F. Epithelium-off photochemical corneal collagen cross-linkage using riboflavin and ultraviolet a for keratoconus and keratectasia: a systematic review and meta-analysis. Ocul. Surf., 2014, 12(3), 202-214.
97. Thakuri, P.S.; Joshi, R.; Basnet, S.; Pandey, S.; Taujale, S.D.; Mishra, N. Antibacterial photodynamic therapy on Staphylococcus aureus and Pseudomonas aeruginosa in-vitro. Nepal Med. Coll. J., 2011, 13(4), 281-284.
98. O'Rourke, J.F.; Dowds, B.C. Dye-mediated photodynamic inactivation of Bacillus subtilis. Biochem. Soc. Trans., 1992, 20(1), 76S.
99. Kashiwabuchi, R.T.; Khan, Y.; Carvalho, F.R.; Hirai, F.; Campos, M.S.; McDonnell, P.J. Antimicrobial susceptibility of photodynamic therapy (UVA/riboflavin) against Staphylococcus aureus. Arq. Bras. Oftalmol., 2012, 75(6), 423-426.
100. Mulrooey, C.A.; O'Brien, E.M.; Morgan, B.J.; Kozlowski, M.C. Perylenequinones: Isolation, synthesis, and biological activity. Eur. J. Org. Chem., 2012, 2012(21), 3887-3904.
101. Miskovsky, P. Hypericin - a new antiviral and antitumor photosensitizer: mechanism of action and interaction with biological macromolecules. Curr. Drug Targets, 2002, 3(1), 55-84.
102. Avato, P.; Raffo, F.; Guglielmi, G.; Vitali, C.; Rosato, A. Extracts from St John's Wort and their antimicrobial activity. Phytother. Res., 2004, 18(3), 230-232.
103. Kiesslich, T.; Krammer, B.; Plaetzer, K. Cellular mechanisms and prospective applications of hypericin in photodynamic therapy. Curr. Med. Chem., 2006, 13(18), 2189-2204.
104. Engelhardt, V.; Krammer, B.; Plaetzer, K. Antibacterial photodynamic therapy using water-soluble formulations of hypericin or mTHPC is effective in inactivation of Staphylococcus aureus. Photochem. Photobiol. Sci., 2010, 9(3), 365-369.
105. de Melo, W.C.; Lee, A.N.; Perussi, J.R.; Hamblin, M.R. Electroporation enhances antimicrobial photodynamic therapy mediated by the hydrophobic photosensitizer, hypericin. Photodiagnosis Photodyn. Ther., 2013, 10(4), 647-650.
106. Hager, B.; Strauss, W.S.; Falk, H. Cationic hypericin derivatives as novel agents with photobactericidal activity: synthesis and photodynamic inactivation of Propionibacterium acnes. Photochem. Photobiol., 2009, 85(5), 1201-1206.
107. Zhenjun, D.; Lown, J.W. Hypocrellins and their use in photosensitization. Photochem. Photobiol., 1990, 52(3), 609-616.
108. Su, Y.; Sun, J.; Rao, S.; Cai, Y.; Yang, Y. Photodynamic antimicrobial activity of hypocrellin A. J. Photochem. Photobiol. B, 2011, 103(1), 29-34.
109. Jiang, Y.; Leung, A.W.; Wang, X.; Zhang, H.; Xu, C. Inactivation of Staphylococcus aureus by photodynamic action of hypocrellin B. Photodiagnosis Photodyn. Ther., 2013, 10(4), 600-606.
110. Daub, M.E. Peroxidation of tobacco membrane lipids by the photosensitizing toxin, cercosporin. Plant Physiol., 1982, 69(6), 1361-1364.
111. Yamazaki, S.; Okube, A.; Akiyama, Y.; Fuwa, K., Cercosporin, a novel photodynamic pigment isolated from Cercospora kikuchii. Agric. Biol. Chem., 1975, 39, 287-288.
112. Melski, J.W.; Tanenbaum, L.; Parrish, J.A.; Fitzpatrick, T.B.; Bleich, H.L. Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial. J. Invest. Dermatol., 1977, 68(6), 328-335.
113. Vatansever, F.; Ferraresi, C.; de Sousa, M.V.; Yin, R.; Rineh, A.; Sharma, S.K.; Hamblin, M.R. Can biowarfare agents be defeated with light? Virulence, 2013, 4(8), 796-852.
114. Margolis-Nunno, H.; Williams, B.; Rywkin, S.; Geacintov, N.; Horowitz, B. Virus sterilization in platelet concentrates with psoralen and ultraviolet A light in the presence of quenchers. Transfusion, 1992, 32(6), 541-547.
115. Harding, A.S.; Schwab, K.J. Using limes and synthetic psoralens to enhance solar disinfection of water (SODIS): a laboratory evaluation with norovirus, Escherichia coli, and MS2. Am. J. Trop. Med. Hyg., 2012, 86(4), 566-572.
116. Ciaravino, V.; McCullough, T.; Cimino, G.; Sullivan, T. Preclinical safety profile of plasma prepared using the INTERCEPT blood system. Vox. Sang., 2003, 85(3), 171-182.
117. Wainwright, M.; Crossley, K.B. Methylene Blue - a therapeutic dye for all seasons? J. Chemother., 2002, 14(5), 431-443.
118. Tseng, S.P.; Teng, L.J.; Chen, C.T.; Lo, T.H.; Hung, W.C.; Chen, H.J.; Hsueh, P.R.; Tsai, J.C. Toluidine blue O photodynamic inactivation on multidrug-resistant Pseudomonas aeruginosa. Lasers Surg. Med., 2009, 41(5), 391-397.
119. Teichert, M.C.; Jones, J.W.; Usacheva, M.N.; Biel, M.A. Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2002, 93(2), 155-160.
120. Junqueira, J.C.; Martins Jda, S.; Faria, R.L.; Colombo, C.E.; Jorge, A.O. Photodynamic therapy for the treatment of buccal candidiasis in rats. Lasers Med. Sci., 2009, 24(6), 877-884.
121. Giroldo, L.M.; Felipe, M.P.; de Oliveira, M.A.; Munin, E.; Alves, L.P.; Costa, M.S. Photodynamic antimicrobial chemotherapy (PACT) with methylene blue increases membrane permeability in Candida albicans. Lasers Med. Sci., 2009, 24(1), 109-112.
122. Pupo, Y.M.; Gomes, G.M.; Santos, E.B.; Chaves, L.; Michel, M.D.; Kozlowski, V.A., Jr.; Gomes, O.M.; Gomes, J.C. Susceptibility of Candida albicans to photodynamic therapy using methylene blue and toluidine blue as photosensitizing dyes. Acta Odontol. Latinoam., 2011, 24(2), 188-192.
123. Kato, I.T.; Prates, R.A.; Sabino, C.P.; Fuchs, B.B.; Tegos, G.P.; Mylonakis, E.; Hamblin, M.R.; Ribeiro, M.S. Antimicrobial photodynamic inactivation inhibits Candida albicans virulence factors and reduces in vivo pathogenicity. Antimicrob. Agents Chemother., 2013, 57(1), 445-451.
124. Gonzales, F.P.; da Silva, S.H.; Roberts, D.W.; Braga, G.U. Photodynamic inactivation of conidia of the fungi Metarhizium anisopliae and Aspergillus nidulans with methylene blue and toluidine blue. Photochem. Photobiol., 2010, 86(3), 653-661.
125. Sharma, M.; Visai, L.; Bragheri, F.; Cristiani, I.; Gupta, P.K.; Speziale, P. Toluidine blue-mediated photodynamic effects on staphylococcal biofilms. Antimicrob. Agents Chemother., 2008, 52(1), 299-305.
126. Zanin, I.C.; Lobo, M.M.; Rodrigues, L.K.; Pimenta, L.A.; Hofling, J.F.; Goncalves, R.B. Photosensitization of in vitro biofilms by toluidine blue O combined with a light-emitting diode. Eur. J. Oral Sci., 2006, 114(1), 64-69.
127. Donnelly, R.F.; McCarron, P.A.; Tunney, M.M.; David Woolfson, A. Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characterisation of a mucoadhesive patch containing toluidine blue O. J. Photochem. Photobiol. B, 2007, 86(1), 59-69.
128. Wong, T.W.; Wang, Y.Y.; Sheu, H.M.; Chuang, Y.C. Bactericidal effects of toluidine blue-mediated photodynamic action on Vibrio vulnificus. Antimicrob. Agents Chemother., 2005, 49(3), 895-902.
129. Tanaka, M.; Mroz, P.; Dai, T.; Huang, L.; Morimoto, Y.; Kinoshita, M.; Yoshihara, Y.; Nemoto, K.; Shinomiya, N.; Seki, S.; Hamblin, M.R. Photodynamic Therapy Can Induce a Protective Innate Immune Response against Murine Bacterial Arthritis via Neutrophil Accumulation. PLoS One, 2012, 7(6), e39823.
130. Nastri, L.; Donnarumma, G.; Porzio, C.; De Gregorio, V.; Tufano, M.A.; Caruso, F.; Mazza, C.; Serpico, R. Effects of toluidine bluemediated photodynamic therapy on periopathogens and periodontal biofilm: in vitro evaluation. Int. J. Immunopathol. Pharmacol., 2010, 23(4), 1125-1132.
131. Komerik, N.; Nakanishi, H.; MacRobert, A.J.; Henderson, B.; Speight, P.; Wilson, M. In vivo killing of Porphyromonas gingivalis by toluidine blue-mediated photosensitization in an animal model. Antimicrob. Agents Chemother., 2003, 47(3), 932-940.
132. Wainwright, M.; Phoenix, D.A.; Laycock, S.L.; Wareing, D.R.; Wright, P.A. Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus. FEMS Microbiol. Lett., 1998, 160(2), 177-181.
133. Wainwright, M.; Phoenix, D.A.; Marland, J.; Wareing, D.R.; Bolton, F.J. A study of photobactericidal activity in the phenothiazinium series. FEMS Immunol. Med. Microbiol., 1997, 19(1), 75-80.
134. Dai, T.; Bil de Arce, V.J.; Tegos, G.P.; Hamblin, M.R. Blue dye and red light: a dynamic combination for prophylaxis and treatment of cutaneous Candida albicans infections in mice Antimicrob. Agents Chemother., 2011, 57, 5710-5717.
135. Ragas, X.; Dai, T.; Tegos, G.P.; Agut, M.; Nonell, S.; Hamblin, M.R. Photodynamic inactivation of Acinetobacter baumannii using phenothiazinium dyes: in-vitro and in-vivo studies. Lasers Surg. Med., 2010, 42(5), 384-390.
136. Lin, C.W.; Shulok, J.R.; Wong, Y.K.; Schanbacher, C.F.; Cincotta, L.; Foley, J.W. Photosensitization, uptake, and retention of phenoxazine Nile blue derivatives in human bladder carcinoma cells. Cancer Res., 1991, 51(4), 1109-1116.
137. Cincotta, L.; Foley, J.W.; MacEachern, T.; Lampros, E.; Cincotta, A.H. Novel photodynamic effects of a benzophenothiazine on two different murine sarcomas. Cancer Res., 1994, 54(5), 1249-1258.
138. Foley, J.W.; Song, X.; Demidova, T.N.; Jalil, F.; Hamblin, M.R. Synthesis and properties of benzo[a]phenoxazinium chalcogen analogues as novel broad-spectrum antimicrobial photosensitizers. J. Med. Chem., 2006, 49(17), 5291-5299.
139. Vecchio, D.; Bhayana, B.; Huang, L.; Carrasco, E.; Evans, C.L.; Hamblin, M.R. Structure-function relationships of Nile blue (EtNBS) derivatives as antimicrobial photosensitizers. Eur. J. Med. Chem., 2014, 75C, 479-491.
140. Ryvolova, M.; Taborsky, P.; Vrabel, P.; Krasensky, P.; Preisler, J. Sensitive determination of erythrosine and other red food colorants using capillary electrophoresis with laser-induced fluorescence detection. J. Chromatogr. A, 2007, 1141(2), 206-211.
141. Schafer, F.; Nicholson, J.A.; Gerritsen, N.; Wright, R.L.; Gillam, D.G.; Hall, C. The effect of oral care feed-back devices on plaque removal and attitudes towards oral care. Int. Dent. J., 2003, 53(6 Suppl 1), 404-408.
142. Wood, S.; Metcalf, D.; Devine, D.; Robinson, C. Erythrosine is a potential photosensitizer for the photodynamic therapy of oral plaque biofilms. J. Antimicrob. Chemother., 2006, 57(4), 680-684.
143. Metcalf, D.; Robinson, C.; Devine, D.; Wood, S. Enhancement of erythrosine-mediated photodynamic therapy of Streptococcus mutans biofilms by light fractionation. J. Antimicrob. Chemother., 2006, 58(1), 190-192.
144. Costa, A.C.; Campos Rasteiro, V.M.; da Silva Hashimoto, E.S.; Araujo, C.F.; Pereira, C.A.; Junqueira, J.C.; Jorge, A.O. Effect of erythrosine- and LED-mediated photodynamic therapy on buccal candidiasis infection of immunosuppressed mice and Candida albicans adherence to buccal epithelial cells. Oral Surg. Oral Med. Oral Pathol. Oral Radiol., 2012, 114(1), 67-74.
145. Bellin, J.S.; Lutwick, L.; Jonas, B. Effects of photodynamic action on E. coli. Arch. Biochem. Biophys., 1969, 132(1), 157-164.
146. Bezman, S.A.; Burtis, P.A.; Izod, T.P.; Thayer, M.A., Photodynamic inactivation of E. coli by rose bengal immobilized on polystyrene beads. Photochem. Photobiol., 1978, 28(3), 325-329.
147. Schafer, M.; Schmitz, C.; Facius, R.; Horneck, G.; Milow, B.; Funken, K.H.; Ortner, J. Systematic study of parameters influencing the action of Rose Bengal with visible light on bacterial cells: comparison between the biological effect and singlet-oxygen production. Photochem. Photobiol., 2000, 71(5), 514-523.
148. Schafer, M.; Schmitz, C.; Horneck, G. High sensitivity of Deinococcus radiodurans to photodynamically-produced singlet oxygen. Int. J. Radiat. Biol., 1998, 74(2), 249-253.
149. Goulart Rde, C.; Bolean, M.; Paulino Tde, P.; Thedei, G., Jr.; Souza, S.L.; Tedesco, A.C.; Ciancaglini, P. Photodynamic therapy in planktonic and biofilm cultures of Aggregatibacter actinomy-cetemcomitans. Photomed. Laser Surg., 2010, 28[Suppl] 1, S53-60.
150. Shrestha, A.; Hamblin, M.R.; Kishen, A. Photoactivated rose bengal functionalized chitosan nanoparticles produce antibacterial/biofilm activity and stabilize dentin-collagen. Nanomedicine, 2014, 10(3), 491-501.
151. Docampo, R.; Moreno, S.N. The metabolism and mode of action of gentian violet. Drug Metab. Rev., 1990, 22(2-3), 161-178.
152. Jurevic, R.J.; Traboulsi, R.S.; Mukherjee, P.K.; Salata, R.A.; Ghannoum, M.A. Oral, H.I.V.A.R.A.M.F.g., Identification of gentian violet concentration that does not stain oral mucosa, possesses anti-candidal activity and is well tolerated. Eur. J. Clin. Microbiol. Infect. Dis., 2011, 30(5), 629-633.
153. Donders, G.G.; Bellen, G.; Mendling, W. Management of recurrent vulvo-vaginal candidosis as a chronic illness. Gynecol. Obstet. Invest., 2010, 70 (4), 306-321.
154. Docampo, R.; Moreno, S.N.; Muniz, R.P.; Cruz, F.S.; Mason, R.P. Light-enhanced free radical formation and trypanocidal action of gentian violet (crystal violet). Science, 1983, 220 (4603), 1292-1295.
155. Ramirez, L.E.; Lages-Silva, E.; Pianetti, G.M.; Rabelo, R.M.; Bordin, J.O.; Moraes-Souza, H. Prevention of transfusion-associated Chagas' disease by sterilization of Trypanosoma cruzi-infected blood with gentian violet, ascorbic acid, and light. Transfusion, 1995, 35 (3), 226-230.
156. Tanaka, M.; Kinoshita, M.; Yoshihara, Y.; Shinomiya, N.; Seki, S.; Nemoto, K.; Hirayama, T.; Dai, T.; Huang, L.; Hamblin, M.R.; Morimoto, Y. Optimal photosensitizers for photodynamic therapy of infections should kill bacteria but spare neutrophils. Photochem. Photobiol., 2012, 88 (1), 227-232.
157. Giraudeau, C.; Moussaron, A.; Stallivieri, A.; Mordon, S.; Frochot, C. Indocyanine green: Photosensitizer or chromophore ? Still a debate. Curr. Med. Chem., 2013 [Epub Ahead of Print].
158. Topaloglu, N.; Gulsoy, M.; Yuksel, S., Antimicrobial photodynamic therapy of resistant bacterial strains by indocyanine green and 809-nm diode laser. Photomed. Laser Surg., 2013, 31 (4), 155-162.
159. Boehm, T.K.; Ciancio, S.G. Diode laser activated indocyanine green selectively kills bacteria. J. Int. Acad. Periodontol., 2011, 13(2), 58-63.
160. George, S.; Hamblin, M.R.; Kishen, A., Uptake pathways of anionic and cationic photosensitizers into bacteria. Photochem. Photobiol. Sci., 2009, 8(6), 788-795.
161. Genina, E.A.; Bashkatov, A.N.; Simonenko, G.V.; Odoevskaya, O.D.; Tuchin, V.V.; Altshuler, G.B., Low-intensity indocyaninegreen laser phototherapy of acne vulgaris: pilot study. J. Biomed. Opt., 2004, 9(4), 828-834.
162. Kim, B.J.; Lee, H.G.; Woo, S.M.; Youn, J.I.; Suh, D.H., Pilot study on photodynamic therapy for acne using indocyanine green and diode laser. J. Dermatol., 2009, 36(1), 17-21.
163. Leite, I.S.; Geralde, M.G.; Salina, A.C.; Medeiros, A.I.; Kurachi, C.; Bagnato, V.S.; Inada, N.M., Photodynamic inactivation of microorganisms which cause pulmonary diseases with infrared light: an in vitro study. Proc. SPIE., 2014, 8927, 89271A.
164. Danilatou, V.; Lydaki, E.; Dimitriou, H.; Papazoglou, T.; Kalmanti, M. Bone marrow purging by photodynamic treatment in children with acute leukemia: cytoprotective action of amifostine. Leuk. Res., 2000, 24 (5), 427-435.
165. Sieber, F.; Spivak, J.L.; Sutcliffe, A.M. Selective killing of leukemic cells by merocyanine 540-mediated photosensitization. Proc. Natl. Acad. Sci. U S A, 1984, 81 (23), 7584-7587.
166. Yamazaki, T.; Sieber, F. Effect of hypothermia on the merocyanine 540-mediated purging of hematopoietic cells. J. Hematother., 1997, 6 (1), 31-39.
167. Lin, H.Y.; Chen, C.T.; Huang, C.T. Use of merocyanine 540 for photodynamic inactivation of Staphylococcus aureus planktonic and biofilm cells. Appl. Environ. Microbiol., 2004, 70 (11), 6453-6458.
168. Shmigol, T.A.; Bekhalo, V.A.; Sysolyatina, C.; Nagurskaya, E.V.; Ermolaeva, S.A.; Potapenko, A.Y. Effect of Sodium Chloride on Aggregation of Merocyanine 540 and Photosensitized Inactivation of Staphylococcus aureus and Pseudomonas aeruginosa. Acta Nat., 2011, 3 (4), 107-113.
169. Sbarra, M.S.; Di Poto, A.; Arciola, C.R.; Saino, E.; Sharma, M.; Bragheri, F.; Cristiani, I.; Speziale, P.; Visai, L. Photodynamic action of merocyanine 540 on Staphylococcus epidermidis biofilms. Int. J. Artif. Organs., 2008, 31 (9), 848-857.
170. Kamkaew, A.; Lim, S.H.; Lee, H.B.; Kiew, L.V.; Chung, L.Y.; Burgess, K. BODIPY dyes in photodynamic therapy. Chem. Soc. Rev. 2013, 42 (1), 77-88.
171. Duman, S.; Cakmak, Y.; Kolemen, S.; Akkaya, E.U.; Dede, Y. Heavy atom free singlet oxygen generation: doubly substituted configurations dominate S1 states of bis-BODIPYs. J. Org. Chem., 2012, 77 (10), 4516-4527.
172. Zhang, X.F.; Yang, X. Singlet oxygen generation and triplet excited-state spectra of brominated BODIPY. J. Phys. Chem. B, 2013, 117 (18), 5533-5539.
173. Caruso, E.; Banfi, S.; Barbieri, P.; Leva, B.; Orlandi, V.T. Synthesis and antibacterial activity of novel cationic BODIPY photosensitizers. J. Photochem. Photobiol. B, 2012, 114, 44-51.
174. Avirah, R.R.; Jayaram, D.T.; Adarsh, N.; Ramaiah, D. Squaraine dyes in PDT: from basic design to in vivo demonstration. Org. Biomol. Chem., 2012, 10 (5), 911-920.
175. Ramaiah, D.; Eckert, I.; Arun, K.T.; Weidenfeller, L.; Epe, B. Squaraine dyes for photodynamic therapy: study of their cytotoxicity and genotoxicity in bacteria and mammalian cells. Photochem. Photobiol., 2002, 76 (6), 672-677.
176. Hotze, E.M.; Labille, J.; Alvarez, P.; Wiesner, M.R. Mechanisms of photochemistry and reactive oxygen production by fullerene suspensions in water. Environ. Sci. Technol., 2008, 42 (11), 4175-4180.
177. Culotta, L.; Koshland, D.E., Jr. Buckyballs: wide open playing field for chemists. Science, 1991, 254 (5039), 1706-1709.
178. Oberdorster, G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J. Intern. Med., 2010, 267 (1), 89-105.
179. Gharbi, N.; Pressac, M.; Hadchouel, M.; Szwarc, H.; Wilson, S.R.; Moussa, F. [60]fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett., 2005, 5 (12), 2578-2585.
180. Tegos, G.P.; Demidova, T.N.; Arcila-Lopez, D.; Lee, H.; Wharton, T.; Gali, H.; Hamblin, M.R. Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem. Biol., 2005, 12 (10), 1127-1135.
181. Huang, L.; Terakawa, M.; Zhiyentayev, T.; Huang, Y.Y.; Sawayama, Y.; Jahnke, A.; Tegos, G.P.; Wharton, T.; Hamblin, M.R. Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials. Nanomedicine, 2010, 6 (3), 442-452.
182. Spesia, M.B.; Milanesio, M.E.; Durantini, E.N. Synthesis, properties and photodynamic inactivation of Escherichia coli by novel cationic fullerene C60 derivatives. Eur. J. Med. Chem., 2008, 43 (4), 853-861.
183. Mroz, P.; Pawlak, A.; Satti, M.; Lee, H.; Wharton, T.; Gali, H.; Sarna, T.; Hamblin, M.R. Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism. Free Radic. Biol. Med., 2007, 43 (5), 711-719.
184. Thota, S.; Wang, M.; Jeon, S.; Maragani, S.; Hamblin, M.R.; Chiang, L.Y. Synthesis and characterization of positively charged pentacationic [60]fullerene monoadducts for antimicrobial photodynamic inactivation. Molecules, 2012, 17 (5), 5225-5243.
185. Lun Pang, C.; Lindsay, R.; Thornton, G. Chemical reactions on rutile TiO2(110). Chem. Soc. Rev., 2008, 37 (10), 2328-2353.
186. Foster, H.A.; Ditta, I.B.; Varghese, S.; Steele, A., Photocatalytic disinfection using titanium dioxide: spectrum and mechanism of antimicrobial activity. Appl. Microbiol. Biotechnol., 2011, 90 (6), 1847-1868.
187. Yin, Z.F.; Wu, L.; Yang, H.G.; Su, Y.H. Recent progress in biomedical applications of titanium dioxide. Phys Chem. Chem. Phys., 2013, 15 (14), 4844-4858.
188. Paramasivam, I.; Jha, H.; Liu, N.; Schmuki, P. A review of photocatalysis using self-organized TiO2 nanotubes and other ordered oxide nanostructures. Small, 2012, 8(20), 3073-3103.
189. Matsunaga, T.; Tomoda, R.; Nakajima, T.; Nakamura, N.; Komine, T. Continuous-sterilization system that uses photosemiconductor powders. Appl. Environ. Microbiol., 1988, 54(6), 1330-1333.
190. McCullagh, C.; Robertson, J.M.; Bahnemann, D.W.; Robertson, P.K. The application of TiO2 photocatalysis for disinfection of water contaminated with pathogenic micro-organisms: a review. Res. Chem. Intermed., 2007, 33, 359-375.
191. Ireland, J.C.; Klostermann, P.; Rice, E.W.; Clark, R.M. Inactivation of Escherichia coli by titanium dioxide photocatalytic oxidation. Appl. Environ. Microbiol., 1993, 59(5), 1668-1670.
192. Pham, H.N.; McDowell, T.; Wilkins, E. Photocatalytically-mediated disinfection of water using TiO2 as a catalyst and sporeforming Bacillus pumilus as a model. J. Environ. Sci. Health, 1995, A30, 627-636.
193. Prasad, G.K.; Ramacharyulu, P.V.; Merwyn, S.; Agarwal, G.S.; Srivastava, A.R.; Singh, B.; Rai, G.P.; Vijayaraghavan, R. Photocatalytic inactivation of spores of Bacillus anthracis using titania nanomaterials. J. Hazard Mater, 2011, 185(2-3), 977-982.
194. Kau, J.H.; Sun, D.S.; Huang, H.H.; Wong, M.S.; Lin, H.C.; Chang, H.H. Role of visible light-activated photocatalyst on the reduction of anthrax spore-induced mortality in mice. PLoS One, 2009, 4(1), e4167.
195. Tsai, T.-M.; Chang, H.-H.; Chang, K.-C.; Liu, Y.-L.; Tseng, C.-C., A comparative study of the bactericidal effect of photocatalytic oxidation by TiO2 on antibiotic resistant and antibiotic-sensitive bacteria. J Chem Technol Biotechnol, 2010, 85, 1642-1653.
196. Yu, J.C.; Ho, W.; Yu, J.; Yip, H.; Wong, P.K.; Zhao, J., Efficient visible-light-induced photocatalytic disinfection on sulfur-doped nanocrystalline titania. Environ. Sci. Technol., 2005, 39(4), 1175-1179.
197. Wu, J.Y.; Li, C.W.; Tsai, C.H.; Chou, C.W.; Chen, D.R.; Wang, G.J. Synthesis of antibacterial TiO2/PLGA composite biofilms. Nanomedicine, 2014, 10(5), 1097-1107.
198. Mitoraj, D.; Janczyk, A.; Strus, M.; Kisch, H.; Stochel, G.; Heczko, P.B.; Macyk, W. Visible light inactivation of bacteria and fungi by modified titanium dioxide. Photochem. Photobiol. Sci., 2007, 6(6), 642-648.
199. Kaye, E.T. Topical antibacterial agents: role in prophylaxis and treatment of bacterial infections. Curr. Clin. Top Infect. Dis., 2000, 20, 43-62.
200. Hamblin, M.R.; O'Donnell, D.A.; Murthy, N.; Contag, C.H.; Hasan, T. Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging. Photochem. Photobiol., 2002, 75(1), 51-57.
201. Hashimoto, M.C.; Prates, R.A.; Kato, I.T.; Nunez, S.C.; Courrol, L.C.; Ribeiro, M.S. Antimicrobial photodynamic therapy on drug-resistant Pseudomonas aeruginosa-induced infection. An in vivo study. Photochem. Photobiol., 2012, 88(3), 590-595.
202. Lu, Z.; Dai, T.; Huang, L.; Kurup, D.B.; Tegos, G.P.; Jahnke, A.; Wharton, T.; Hamblin, M.R., Photodynamic therapy with a cationic functionalized fullerene rescues mice from fatal wound infections. Nanomedicine (Lond), 2010, 5(10), 1525-1533.
203. Brown, S. Clinical antimicrobial photodynamic therapy: phase II studies in chronic wounds. J. Natl. Compr. Cancer Netw., 2012, 10 Suppl 2, S80-83.
204. Mannucci, E.; Genovese, S.; Monami, M.; Navalesi, G.; Dotta, F.; Anichini, R.; Romagnoli, F.; Gensini, G. Photodynamic topical antimicrobial therapy for infected foot ulcers in patients with diabetes: a randomized, double-blind, placebo-controlled study-the D.A.N.T.E (Diabetic ulcer Antimicrobial New Topical treatment Evaluation) study. Acta Diabetol., 2014, 51(3), 435-440.
205. Kjeldstad, B.; Johnsson, A. An action spectrum for blue and near ultraviolet inactivation of Propionibacterium acnes; with emphasis on a possible porphyrin photosensitization. Photochem. Photobiol., 1986, 43(1), 67-70.
206. Bissonnette, R., Treatment of acne with photodynamic therapy. G. Ital. Dermatol. Venereol., 2011, 146(6), 445-456.
207. Sakamoto, F.H.; Torezan, L.; Anderson, R.R. Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part II. Understanding parameters for acne treatment with photodynamic therapy. J. Am. Acad. Dermatol., 2010, 63(2), 195-211; quiz 211-192.
208. Taylor, M.N.; Gonzalez, M.L. The practicalities of photodynamic therapy in acne vulgaris. Br. J. Dermatol., 2009, 160(6), 1140-1148.
209. Morton, C.A. Photodynamic therapy in acne: can we achieve therapeutic gain without pain? Br. J. Dermatol., 2011, 165(5), 932-933.
210. Sardi, J.C.; Scorzoni, L.; Bernardi, T.; Fusco-Almeida, A.M.; Mendes Giannini, M.J. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J. Med. Microbiol., 2013, 62(Pt 1), 10-24.
211. Smijs, T.G.; Pavel, S. The susceptibility of dermatophytes to photodynamic treatment with special focus on Trichophyton rubrum. Photochem. Photobiol., 2011, 87(1), 2-13.
212. Dai, T.; Fuchs, B.B.; Coleman, J.J.; Prates, R.A.; Astrakas, C.; St Denis, T.G.; Ribeiro, M.S.; Mylonakis, E.; Hamblin, M.R.; Tegos, G.P. Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Front Microbiol., 2012, 3, 120.
213. Javed, F.; Samaranayake, L.P.; Romanos, G.E. Treatment of oral fungal infections using antimicrobial photodynamic therapy: a systematic review of currently available evidence. Photochem. Photobiol. Sci., 2014, 13(5), 726-734.
214. Calzavara-Pinton, P.G.; Venturini, M.; Sala, R. A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. J. Photochem. Photobiol. B, 2005, 78(1), 1-6.
215. Souza, L.W.; Souza, S.V.; Botelho, A.C. Distal and lateral toenail onychomycosis caused by Trichophyton rubrum: treatment with photodynamic therapy based on methylene blue dye. An Bras. Dermatol., 2014, 89(1), 184-186.
216. Silva, A.P.; Kurachi, C.; Bagnato, V.S.; Inada, N.M. Fast elimination of onychomycosis by hematoporphyrin derivativephotodynamic therapy. Photodiagnosis Photodyn. Ther., 2013, 10(3), 328-330.
217. Shiota, S.; Yamaoka, Y., Strategy for the treatment of Helicobacter pylori infection. Curr. Pharm. Des., 2014, 20(28), 4489-4500.
218. Choi, S.; Lee, H.; Chae, H. Synergistic in vitro photodynamic antimicrobial activity of methylene blue and chitosan against Helicobacter pylori 26695. Photodiagnosis Photodyn. Ther., 2014, 11(4), 526-32.
219. Choi, S.S.; Lee, H.K.; Chae, H.S. In vitro photodynamic antimicrobial activity of methylene blue and endoscopic white light against Helicobacter pylori 26695. J. Photochem. Photobiol. B, 2010, 101(3), 206-209.
220. Bedwell, J.; Holton, J.; Vaira, D.; MacRobert, A.J.; Bown, S.G. In vitro killing of Helicobacter pylori with photodynamic therapy. Lancet, 1990, 335(8700), 1287.
221. Wilder-Smith, C.H.; Wilder-Smith, P.; Grosjean, P.; van den Bergh, H.; Woodtli, A.; Monnier, P.; Dorta, G.; Meister, F.; Wagnieres, G. Photoeradication of Helicobacter pylori using 5-aminolevulinic acid: preliminary human studies. Lasers Surg. Med., 2002, 31(1), 18-22.
222. Hamblin, M.R.; Viveiros, J.; Yang, C.; Ahmadi, A.; Ganz, R.A.; Tolkoff, M.J. Helicobacter pylori accumulates photoactive porphyrins and is killed by visible light. Antimicrob. Agents Chemother., 2005, 49(7), 2822-2827.
223. Ganz, R.A.; Viveiros, J.; Ahmad, A.; Ahmadi, A.; Khalil, A.; Tolkoff, M.J.; Nishioka, N.S.; Hamblin, M.R. Helicobacter pylori in patients can be killed by visible light. Lasers Surg. Med., 2005, 36(4), 260-265.
224. Lembo, A.J.; Ganz, R.A.; Sheth, S.; Cave, D.; Kelly, C.; Levin, P.; Kazlas, P.T.; Baldwin, P.C., 3rd; Lindmark, W.R.; McGrath, J.R.; Hamblin, M.R. Treatment of Helicobacter pylori infection with intra-gastric violet light phototherapy: A pilot clinical trial. Lasers Surg. Med., 2009, 41(5), 337-344.
225. Sigusch, B.W.; Pfitzner, A.; Albrecht, V.; Glockmann, E. Efficacy of photodynamic therapy on inflammatory signs and two selected periodontopathogenic species in a beagle dog model. J. Periodontol., 2005, 76(7), 1100-1105.
226. Berakdar, M.; Callaway, A.; Eddin, M.F.; Ross, A.; Willershausen, B. Comparison between scaling-root-planing (SRP) and SRP/photodynamic therapy: six-month study. Head Face Med., 2012, 8, 12.
227. Neugebauer, J.; Jozsa, M.; Kubler, A. Antimicrobial photodynamic therapy for prevention of alveolar ostitis and post-extraction pain. Mund. Kiefer. Gesichtschir., 2004, 8(6), 350-355.
228. Lombard, G.F.; Tealdi, S.; Lanotte, M.M. In Photodynamic therapy of tumors and other diseases, Jori, G.; Perria, C.A., Eds.; Edizione Libreria Progetto: Padova, Italy, 1985, pp. 363-366.
229. Phillips, M.; Rosenberg, A.; Shopsin, B.; Cuff, G.; Skeete, F.; Foti, A.; Kraemer, K.; Inglima, K.; Press, R.; Bosco, J. Preventing surgical site infections: a randomized, open-label trial of nasal mupirocin ointment and nasal povidone-iodine solution. Infect. Control. Hosp. Epidemiol., 2014, 35(7), 826-832.
230. Bryce, E.; Wong, T.; Roscoe, D. In AMMI-CACMID Annual Conference; Can J Inf Dis Med. Micro Vancouver, 2012; Vol. 23, p. 34.
231. Bryce, E.; Wong, T.; Roscoe, D.; Forrester, L.; Masri, B. A novel immediate pre-operative decolonization strategy reduces surgical site infections. Antimicrob. Resist. Infect. Control, 2013, 2, 010.
232. Biel, M.A.; Sievert, C.; Usacheva, M.; Teichert, M.; Wedell, E.; Loebel, N.; Rose, A.; Zimmermann, R. Reduction of endotracheal tube biofilms using antimicrobial photodynamic therapy. Lasers Surg. Med., 2011, 43(7), 586-590.
233. Biel, M.A.; Pedigo, L.; Gibbs, A.; Loebel, N. Photodynamic therapy of antibiotic-resistant biofilms in a maxillary sinus model. Int. Forum Allergy Rhinol, 2013, 3(6), 468-473.
234. Biel, M.A.; Sievert, C.; Usacheva, M.; Teichert, M.; Balcom, J. Antimicrobial photodynamic therapy treatment of chronic recurrent sinusitis biofilms. Int. Forum Allergy Rhinol, 2011, 1(5), 329-334.